Table 1.
Main Prevalence Studies of Tremor in Multiple Sclerosis
| Reference | Sample | Prevalence |
| Weinshenker et al.9 | 259 patients selected from a regional multiple sclerosis clinic (Ontario, USA) | 33% |
| Alusi et al.10 | 100 patients randomly selected from a London multiple sclerosis unit | 58% (Severe in 15%) |
| Pittock et al.11 | 200 patients selected from a community-based study (Minnesota, USA) | 25.5% (Severe in 3%) |
Table 2.
Treatment Options for Multiple Sclerosis Tremor
| Surgical treatment | |
| Deep brain stimulation thalamotomy | Both are comparable procedures for tremor suppression |
| Pharmacological agents | |
| Insufficient evidence to support or refute the efficacy. Possibly effective | |
| Topiramate | |
| Riluzole | |
| Rituximab | |
| Isoniazid | |
| Carbamazepine | |
| Gluthetimide | |
| Intratecal baclofen | |
| Botulinum toxin type A | |
| They probably do not reduce multiple sclerosis tremor | |
| Levetiracetam | |
| Propanolol | |
| Ondansetron | |
| It should not be considered for treatment of multiple sclerosis tremor | |
| Cannabis | |